Medizinische Universitätsklinik Bochum

www.medunikkh.de

Power/ AIO-STO-0309 Studie geschlossen 21.06.2016 An open-label, randomized phase III trial of cisplatin and 5-fluorouracil with or without panitumumab for patients with non-resectable, advanced or metastatic eosophagal squamous cell cancer

AIO-STO-0309 (POWER)
An open-label, randomized phase III trial of cisplatin and 5-
fluorouracil with or without panitumumab for patients with
nonresectable, advanced or metastatic esophageal squamous
cell cancer
Studienleitung: PD Dr. Möhler
AIO Studie

Ansprechpartner